首页 > Surrogacy process > Thailand CEF Chiang Mai Hospital IVF Process Technology Assessment and Applicable Population Analysis

Thailand CEF Chiang Mai Hospital IVF Process Technology Assessment and Applicable Population Analysis

Thailand CEF Chiang Mai Hospital (CEF Fertility Center Chiang Mai) is a reproductive center in the Chiang Mai region with an independent embryology laboratory, specializing in embryo culture technology and PGT genetic screening. This article provides reference information from five dimensions: technical capability, treatment process, time schedule, cost structure, and applicable population, helping those in need establish a reasonable cognitive framework.

Based on clinical pathways and laboratory technical standards in the assisted reproduction industry, this article provides a decomposed analysis of the IVF services at Thailand CEF Chiang Mai Hospital. The content covers technical positioning, applicable population, operational procedures, time planning, and cost structure, without involving success rate promises or institutional promotion.

Core Features of IVF at CEF Chiang Mai Hospital

Thailand CEF Chiang Mai Hospital (CEF Fertility Center Chiang Mai) is a center among assisted reproduction institutions in the Chiang Mai region that possesses an independent embryology laboratory and can independently perform embryo culture and PGT genetic screening. Its technical pathway focuses on the following three aspects:

  • Embryo Culture System: Utilizes continuous sequential culture media and a time-lapse monitoring system for real-time observation of embryo development, reducing human interference.
  • PGT Genetic Screening: The laboratory can independently perform embryo biopsy and genetic testing, covering chromosomal aneuploidy screening (PGT-A) and single gene disorder testing (PGT-M), without the need to send samples out.
  • Frozen-Thawed Embryo Transfer: All embryos are cryopreserved using vitrification technology. Transfer is scheduled after a cumulative cycle, avoiding the impact of fresh cycle ovarian stimulation on endometrial receptivity.

These three technical characteristics determine the main service population of this center: those with high requirements for embryo quality, those needing genetic screening, or those who have experienced abnormal embryo development at other centers.

Reproductive Doctor's Perspective: Laboratory Capability is the Core Variable in Choice

In the field of assisted reproduction, clinical ovarian stimulation protocols are highly homogenized. The variable that truly causes differences between centers is the technical level of the embryology laboratory. This is specifically reflected in:

  • Choice of Fertilization Method: Whether the laboratory can accurately choose between IVF or ICSI based on semen parameters, and whether it has supplementary techniques like IMSI (Intracytoplasmic Morphologically Selected Sperm Injection).
  • Stability of Embryo Culture: The air quality, temperature control, and pH maintenance capability of the incubator directly affect the embryo's cleavage and blastocyst formation rate.
  • Timing of Biopsy and Freezing: The timing of PGT biopsy (Day 5 or Day 6) and the embryo survival rate after freezing and thawing are direct indicators of laboratory maturity.

The laboratory at CEF Chiang Mai Hospital meets international reproductive center standards in terms of hardware configuration. However, individual embryo development results are influenced by multiple factors such as the woman's age, egg quality, and sperm DNA fragmentation rate. Laboratory technology cannot fully compensate for the inherent defects in gamete quality.

Differences and Assessment Strategies for Different Age Groups

Age is an independent and the strongest predictive factor affecting IVF outcomes. The assessment pathways at CEF Chiang Mai Hospital for different age groups are as follows:

Age Range Core Assessment Indicators Common Management Strategies Main Risks
≤35 years AMH, Antral Follicle Count, Semen Analysis Conventional ovarian stimulation, fresh or frozen embryo transfer Ovarian Hyperstimulation Syndrome
36-40 years AMH, FSH, Chromosome Karyotype Analysis PGT-A screening, transfer after embryo accumulation Increased embryo aneuploidy rate
41-43 years AMH, FSH, Antral Follicle Count, Sperm DNA Fragmentation Rate Multiple ovarian stimulation cycles for embryo accumulation, PGT-A screening Reduced number of oocytes retrieved, low embryo utilization rate
≥44 years AMH, FSH, Chromosome Karyotype, Uterine Cavity Assessment Evaluation for egg or embryo donation Oocyte chromosomal abnormality rate exceeds 80%

For individuals over 40, CEF Chiang Mai Hospital recommends completing a full ovarian reserve assessment and genetic counseling before starting a cycle, and developing a treatment plan that includes alternative options.

Easily Overlooked Details: Laboratory Quality Control and Embryo Grading

When evaluating the technical level of CEF Chiang Mai Hospital, in addition to focusing on hardware equipment, it is also important to understand the following easily overlooked details:

  • Frequency of Culture Media Change: A stable culture environment requires regular media changes and endotoxin testing. The standardization of this operation directly affects the consistency of embryo development.
  • Transparency of Blastocyst Grading Standards: Grading standards for blastocysts vary between laboratories. CEF Chiang Mai Hospital uses the Gardner grading system, but patients should request specific grading reports (e.g., 4AA, 4AB) rather than just descriptions like "good quality" or "suitable for transfer."
  • Number and Quality of Biopsied Cells: PGT biopsy typically takes 5-8 trophectoderm cells. Too few cells may affect test accuracy, while too many may impact subsequent embryo development.
  • Duration of Cryopreservation and Survival Rate: The theoretical survival rate for vitrification exceeds 95%, but the actual survival rate is influenced by the operator's experience and the stability of the liquid nitrogen storage equipment.

These details are often overlooked in routine consultations but are important criteria for judging the true level of a laboratory.

Actual Process: Complete Pathway from Initial Consultation to Transfer

The IVF process at CEF Chiang Mai Hospital is divided into the following seven steps, some of which can be combined or the order adjusted:

  1. Online Pre-screening and Document Submission: Submit basic examination reports from the last 3 months for both partners (sex hormone panel, AMH, semen analysis, infectious disease screening, chromosome karyotype). The medical team conducts a preliminary assessment.
  2. First Visit to Thailand (Day 2-3 of Menstrual Cycle): Arrive in Chiang Mai for an on-site ultrasound scan and hormone level verification to confirm the start of ovarian stimulation.
  3. Ovarian Stimulation Monitoring (Approximately 10-14 days): Ultrasound and hormone monitoring every 1-2 days, adjusting medication dosage based on follicle development.
  4. Egg Retrieval Surgery (Under General Anesthesia): Transvaginal egg retrieval guided by ultrasound. The procedure takes about 15-20 minutes, followed by a 2-3 hour observation period.
  5. Embryo Culture and PGT Testing (5-7 days + 2-3 weeks): Blastocyst grading and biopsy are performed on Day 5-6 after egg retrieval. The biopsy sample is sent for PGT analysis, with results expected in 2-3 weeks.
  6. Second Visit to Thailand (Day 14-18 of Menstrual Cycle): Based on PGT results, select a transferable embryo for frozen embryo transfer (using an artificial cycle or natural cycle for endometrial preparation).
  7. Luteal Phase Support and Pregnancy Test (12-14 days after transfer): Progesterone medication is used for luteal phase support after transfer. A blood test for HCG is performed on Day 12-14 to confirm pregnancy.

The entire cycle requires two visits to Thailand. The duration of each stay is approximately 15-18 days for the first visit and 5-7 days for the second, with an interval of about 4-6 weeks between visits.

Specific Time Planning

For individuals who need to arrange work and life, the following timeline can be used as a reference:

Time Point Activity Time Required Notes
1-2 months before starting Complete all pre-operative tests 1-2 weeks AMH, chromosome tests, etc., need to be scheduled in advance
First visit to Thailand Ovarian stimulation + Egg retrieval + Embryo culture 15-18 days It is recommended to allow 2 buffer days
PGT waiting period Return home and wait for test results 2-3 weeks Normal life and work can continue during this time
Second visit to Thailand Endometrial preparation + Frozen embryo transfer 5-7 days Need to confirm endometrial thickness meets requirements
After transfer Luteal phase support + Pregnancy test 14 days Monitoring can be done in home country

The total cycle duration is approximately 2.5-3 months, with a combined stay in Thailand of about 20-25 days. If a fresh embryo transfer is chosen (without PGT), only one visit to Thailand is needed, lasting about 18-22 days. However, the pregnancy rate for fresh transfers is generally lower than for frozen embryo transfers.

Cost Structure and Influencing Factors

The total cost of IVF at CEF Chiang Mai Hospital consists of the following components. The cost range varies depending on individual circumstances:

  • Medical Costs:
    • Ovarian stimulation medication: Approximately 20,000 - 40,000 RMB, depending on the type (imported/domestic) and dosage.
    • Egg retrieval surgery and laboratory procedures: Approximately 40,000 - 60,000 RMB, including egg retrieval, ICSI, and embryo culture.
    • PGT genetic screening: Approximately 20,000 - 30,000 RMB per cycle, charged per embryo (about 4,000 - 6,000 RMB per embryo).
    • Transfer surgery: Approximately 10,000 - 20,000 RMB, including endometrial preparation and the transfer procedure.
  • Non-Medical Costs:
    • Flights and accommodation: Approximately 15,000 - 30,000 RMB, depending on length of stay and accommodation standards.
    • Translation and coordination services: If needed, approximately 5,000 - 10,000 RMB.
    • Food and transportation: Approximately 5,000 - 10,000 RMB.

The total cost typically ranges from 120,000 to 200,000 RMB. The main influencing factors are the response to ovarian stimulation medication (determining dosage and number of cycles), the number of embryos undergoing PGT testing, and whether additional cycles are needed to accumulate embryos.

Interpretation of Test Indicators: Which Data are Key Decision-Making Criteria

Before deciding whether to choose CEF Chiang Mai Hospital for IVF, the following test indicators are the core basis for the doctor's assessment:

  • AMH (Anti-Müllerian Hormone): An indicator of ovarian reserve. AMH ≥ 1.5 ng/ml suggests normal ovarian reserve, 0.5-1.5 ng/ml suggests diminished reserve, and < 0.5 ng/ml suggests severely diminished reserve. For individuals with AMH < 0.5, CEF Chiang Mai Hospital typically recommends an assessment egg retrieval cycle first, and then decides whether to proceed based on the number of oocytes retrieved.
  • FSH (Follicle-Stimulating Hormone): FSH level on Day 2-3 of the menstrual cycle reflects ovarian function. FSH < 8 IU/L is normal, 8-12 IU/L is borderline elevated, and > 12 IU/L indicates diminished ovarian function.
  • Antral Follicle Count (AFC): The total number of antral follicles in both ovaries seen on ultrasound. The normal range is 8-12. AFC < 5 suggests diminished ovarian reserve and potentially limited oocyte yield.
  • Sperm DNA Fragmentation Index (DFI): DFI < 15% is normal, 15-30% is moderately elevated, and > 30% is significantly elevated. Elevated DFI can affect embryo developmental potential and blastocyst formation rate.

After a comprehensive assessment of these indicators, the doctor can determine whether the patient is suitable for IVF at this center and what type of ovarian stimulation protocol and adjunctive techniques should be used.

Suitable and Unsuitable Populations

Based on the technical characteristics and laboratory capabilities of CEF Chiang Mai Hospital, the following populations are more suitable for choosing this center:

  • Suitable Populations:
    • Individuals with normal or mildly diminished ovarian reserve (AMH ≥ 1.0 ng/ml), expected to yield a sufficient number of eggs.
    • Those with a clear need for genetic screening, such as chromosomal translocations, single gene disorders, or a history of recurrent miscarriage.
    • Individuals who have previously experienced embryo developmental arrest or low blastocyst formation rates at other centers.
    • Those with high requirements for embryo quality who are willing to adopt a strategy of embryo accumulation combined with PGT screening.
    • Individuals who can arrange two visits to Thailand and have a basic understanding of Chiang Mai's climate and living environment.
  • Unsuitable Populations:
    • Individuals with severely diminished ovarian reserve (AMH < 0.5 ng/ml), where the expected oocyte yield is very low, making the economic and physiological cost-benefit of direct IVF unfavorable.
    • Those with severe uterine pathologies (e.g., intrauterine adhesions, endometrial tuberculosis, severe adenomyosis) that require treatment before considering embryo transfer.
    • Individuals who cannot accept a frozen embryo transfer protocol and insist on a fresh transfer without PGT screening.
    • Those with serious systemic diseases (e.g., uncontrolled hypertension, diabetes, autoimmune diseases) that require stabilization before proceeding.

For unsuitable populations, the doctors at CEF Chiang Mai Hospital typically clearly state this during the initial consultation and suggest other feasible alternatives, such as egg or embryo donation.

Doctor's Advice: A Systematic Assessment Framework Before Decision-Making

As a reproductive doctor, before advising a patient to choose any reproductive center, a systematic evaluation and expectation management are necessary. For those considering Thailand CEF Chiang Mai Hospital, the following suggestions have general reference value:

  • Complete all basic tests before making a decision: Do not decide whether to go based on a single indicator like AMH or FSH. A complete assessment includes both partners' chromosomes, semen analysis, uterine cavity evaluation, and infectious disease screening. All are essential.
  • Identify the primary problem: If the main issue is a low oocyte yield due to diminished ovarian reserve, laboratory technology cannot fundamentally solve this. What is needed is a reasonable ovarian stimulation protocol and patience for multiple accumulation cycles. If the main issue is abnormal embryo development or genetic risk, then the laboratory's embryo culture and PGT capabilities are the core factors in the choice.
  • Establish a reasonable time expectation: From the initial consultation to the completion of the transfer, the entire cycle takes 2.5-3 months. If time is limited (e.g., due to advanced age), plan ahead to avoid hasty decisions under time pressure.
  • Understand the limitations of PGT: PGT-A can screen for chromosomal aneuploidies but cannot detect all genetic diseases nor completely rule out chromosomal mosaicism. Furthermore, the long-term effects of PGT biopsy on the embryo are still under study. Current evidence suggests no significant adverse effects on postnatal development, but sample sizes are limited.
  • Have a backup plan: There is always a possibility of failure in any IVF cycle. Before starting a cycle, discuss with your doctor what the plan will be if the current cycle fails—whether to try again or switch to another option (such as egg donation, adoption, etc.)—to avoid decision-making confusion after a failure.

Risk Reminder

IVF is an invasive medical procedure with clear medical risks and physiological burdens. Common risks include:

  • Ovarian Hyperstimulation Syndrome (OHSS): After ovarian stimulation, the ovaries enlarge, potentially causing bloating, abdominal pain, nausea, and in severe cases, requiring hospitalization. CEF Chiang Mai Hospital uses GnRH antagonist protocols and frozen embryo transfer strategies, which can significantly reduce the incidence of OHSS.
  • Risks of Egg Retrieval Surgery: The egg retrieval procedure may involve puncture site bleeding, pelvic infection, or injury to surrounding organs, with an incidence rate of about 0.1-0.5%.
  • Risk of Multiple Pregnancy: Transferring two embryos increases the probability of multiple pregnancies. Pregnancy complications (preterm birth, miscarriage, gestational hypertension) are significantly higher in multiple pregnancies compared to singletons. CEF Chiang Mai Hospital routinely recommends single embryo transfer, especially in cycles with PGT screening.
  • Embryo Transfer Failure and Miscarriage: Even when transferring a chromosomally normal embryo, there is still a 30-40% chance of implantation failure or early miscarriage. This is related to factors such as maternal immune status, endometrial receptivity, and embryonic epigenetics.

Fully understanding these risks and implementing individualized risk prevention under the guidance of a doctor are prerequisites for safely completing an IVF cycle.

This article is based on general clinical pathways and laboratory technical standards in the assisted reproduction industry. It is intended to provide knowledge for reference and does not constitute specific medical advice. All medical decisions should be made based on face-to-face communication with a licensed physician.

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670